TRIM19/PML restricts HIV infection in a cell type-dependent manner

Viruses

Volumn 8, Issue 1, 2016, Pages

  Kahle, Tanja ^a   Volkmann, Bianca ^a   Eissmann, Kristin ^a   Herrmann, Alexandra ^a   Schmitt, Sven ^a,b   Wittmann, Sabine ^a   Merkel, Laura ^a   Reuter, Nina ^a   Stamminger, Thomas ^a   Gramberg, Thomas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

HIV 1; Intrinsic immunity; ND10; PML; Retrovirus; TRIM19

Indexed keywords

NUCLEAR PROTEIN; PML PROTEIN, HUMAN; PML PROTEIN, MOUSE; PROMYELOCYTIC LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; C57BL MOUSE; FIBROBLAST; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOUSE; PHYSIOLOGY; SPECIES DIFFERENCE; T LYMPHOCYTE; VIROLOGY;

ANIMALS; FIBROBLASTS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; PROMYELOCYTIC LEUKEMIA PROTEIN; SPECIES SPECIFICITY; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84982720013     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8010002     Document Type: Article

References (35)

1. Nisole, S.; Stoye, J.P.; Saib, A. TRIM family proteins: Retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3, 799-808. [CrossRef] [PubMed].
2. Reymond, A.; Meroni, G.; Fantozzi, A.; Merla, G.; Cairo, S.; Luzi, L.; Riganelli, D.; Zanaria, E.; Messali, S.; Cainarca, S.; et al. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20, 2140-2151. [CrossRef] [PubMed]
3. Bernardi, R.; Pandolfi, P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 2007, 8, 1006-1016. [CrossRef] [PubMed].
4. Shen, T.H.; Lin, H.K.; Scaglioni, P.P.; Yung, T.M.; Pandolfi, P.P. The mechanisms of PML-nuclear body formation. Mol. Cell 2006, 24, 331-339. [CrossRef] [PubMed].
5. Salomoni, P.; Pandolfi, P.P. The role of PML in tumor suppression. Cell 2002, 108, 165-170. [CrossRef].
6. Dellaire, G.; Bazett-Jones, D.P. PML nuclear bodies: Dynamic sensors of DNA damage and cellular stress. Bioessays 2004, 26, 963-977. [CrossRef] [PubMed].
7. Takahashi, Y.; Lallemand-Breitenbach, V.; Zhu, J.; de Thé, H. PML nuclear bodies and apoptosis. Oncogene 2004, 23, 2819-2824. [CrossRef] [PubMed].
8. Tavalai, N.; Stamminger, T. Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res. 2011, 157, 128-133. [CrossRef] [PubMed].
9. Everett, R.D.; Chelbi-Alix, M.K. PML and PML nuclear bodies: Implications in antiviral defence. Biochimie 2007, 89, 819-830. [CrossRef] [PubMed].
10. Chelbi-Alix, M.K.; de Thé, H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 1999, 18, 935-941. [CrossRef] [PubMed].
11. Everett, R.D.; Boutell, C.; Orr, A. Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J. Virol. 2004, 78, 1763-1774. [CrossRef] [PubMed].
12. Boutell, C.; Everett, R.D. The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and ubiquitinates p53. J. Biol. Chem. 2003, 278, 36596-36602. [CrossRef] [PubMed].
13. Uchil, P.D.; Quinlan, B.D.; Chan,W.T.; Luna, J.M.; Mothes,W. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 2008, 4, e16. [CrossRef] [PubMed].
14. Stremlau, M.; Owens, C.M.; Perron, M.J.; Kiessling, M.; Autissier, P.; Sodroski, J. The cytoplasmic body component TRIM5_ restricts HIV-1 infection in old world monkeys. Nature 2004, 427, 848-853. [CrossRef] [PubMed].
15. Wu, X.; Anderson, J.L.; Campbell, E.M.; Joseph, A.M.; Hope, T.J. Proteasome inhibitors uncouple rhesus TRIM5_ restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. USA 2006, 103, 7465-7470. [CrossRef] [PubMed].
16. Stremlau, M.; Perron, M.; Lee, M.; Li, Y.; Song, B.; Javanbakht, H.; Diaz-Griffero, F.; Anderson, D.J.; Sundquist, W.I.; Sodroski, J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5_ restriction factor. Proc. Natl. Acad. Sci. USA 2006, 103, 5514-5519. [CrossRef] [PubMed].
17. Pertel, T.; Hausmann, S.; Morger, D.; Zuger, S.; Guerra, J.; Lascano, J.; Reinhard, C.; Santoni, F.A.; Uchil, P.D.; Chatel, L.; et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472, 361-365. [CrossRef] [PubMed]
18. Turelli, P.; Doucas, V.; Craig, E.; Mangeat, B.; Klages, N.; Evans, R.; Kalpana, G.; Trono, D. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: Interference with early steps of viral replication. Mol. Cell 2001, 7, 1245-1254. [CrossRef].
19. Berthoux, L.; Towers, G.J.; Gurer, C.; Salomoni, P.; Pandolfi, P.P.; Luban, J. As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J. Virol. 2003, 77, 3167-3180. [CrossRef] [PubMed].
20. Bell, P.; Montaner, L.J.; Maul, G.G. Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J. Virol. 2001, 75, 7683-7691. [CrossRef] [PubMed].
21. Lusic, M.; Marini, B.; Ali, H.; Lucic, B.; Luzzati, R.; Giacca, M. Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells. Cell Host Microbe 2013, 13, 665-677. [CrossRef] [PubMed].
22. Jahn, G.; Knust, E.; Schmolla, H.; Sarre, T.; Nelson, J.A.; McDougall, J.K.; Fleckenstein, B. Predominant immediate-early transcripts of human cytomegalovirus AD 169. J. Virol. 1984, 49, 363-370. [PubMed].
23. Wagenknecht, N.; Reuter, N.; Scherer, M.; Reichel, A.; Muller, R.; Stamminger, T. Contribution of the major ND10 proteins PML, hDaxx and Sp100 to the regulation of human cytomegalovirus latency and lytic replication in the monocytic cell line THP-1. Viruses 2015, 7, 2884-2907. [CrossRef] [PubMed].
24. Gramberg, T.; Kahle, T.; Bloch, N.; Wittmann, S.; Mullers, E.; Daddacha, W.; Hofmann, H.; Kim, B.; Lindemann, D.; Landau, N.R. Restriction of diverse retroviruses by SAMHD1. Retrovirology 2013, 10. [CrossRef] [PubMed]
25. Muller, B.; Daecke, J.; Fackler, O.T.; Dittmar, M.T.; Zentgraf, H.; Krausslich, H.G. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 2004, 78, 10803-10813. [CrossRef] [PubMed].
26. Connor, R.I.; Chen, B.K.; Choe, S.; Landau, N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206, 935-944. [CrossRef] [PubMed].
27. Stansell, E.; Apkarian, R.; Haubova, S.; Diehl, W.E.; Tytler, E.M.; Hunter, E. Basic residues in the Mason-Pfizer monkey virus gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J. Virol. 2007, 81, 8977-8988. [CrossRef] [PubMed].
28. Zufferey, R.; Nagy, D.; Mandel, R.J.; Naldini, L.; Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15, 871-875. [CrossRef] [PubMed]
29. Sinzger, C.; Digel, M.; Jahn, G. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 2008, 325, 63-83. [PubMed].
30. Zebboudj, A.; Maroui, M.A.; Dutrieux, J.; Touil-Boukoffa, C.; Bourouba, M.; Chelbi-Alix, M.K.; Nisole, S. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells. Biochimie 2014, 107, 247-256. [CrossRef] [PubMed].
31. Munk, C.; Brandt, S.M.; Lucero, G.; Landau, N.R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. USA 2002, 99, 13843-13848. [CrossRef] [PubMed].
32. Liu, J.X.; Zhou, G.B.; Chen, S.J.; Chen, Z. Arsenic compounds: Revived ancient remedies in the fight against human malignancies. Curr. Opin. Chem. Biol. 2012, 16, 92-98. [CrossRef] [PubMed].
33. Mei, N.; Lee, J.; Sun, X.; Xing, J.Z.; Hanson, J.; Le, X.C.; Weinfeld, M. Genetic predisposition to the cytotoxicity of arsenic: The role of DNA damage and ATM. FASEB J. 2003, 17, 2310-2312. [CrossRef] [PubMed].
34. Fleischer, S.; Wiemann, S.; Will, H.; Hofmann, T.G. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies. Exp. Cell Res. 2006, 312, 901-912. [CrossRef] [PubMed].
35. Cuchet, D.; Sykes, A.; Nicolas, A.; Orr, A.; Murray, J.; Sirma, H.; Heeren, J.; Bartelt, A.; Everett, R.D. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J. Cell Sci. 2011, 124, 280-291. [CrossRef] [PubMed].